Target intelligence / Profile preview

Hemoglobin subunit alpha 1 (HBA1)

Target
HBA1
Molecular classification
Other
01

Overview

Hemoglobin subunit alpha 1 (HBA1) is a critical protein component of the adult hemoglobin tetramer (HbA), which consists of two alpha and two beta subunits. Encoded by the HBA1 gene, this protein is primarily responsible for the transport of oxygen from the lungs to peripheral tissues and the delivery of carbon dioxide back to the lungs. Beyond its primary role in gas exchange, HBA1 has non-canonical functions, such as modulating nitric oxide signaling at myoendothelial junctions to regulate vascular reactivity and exhibiting peroxidase activity. Defects in HBA1, including deletions and point mutations, are the underlying cause of alpha-thalassemia and other hemoglobinopathies, which result in impaired red blood cell function and anemia. In conditions like sickle cell disease, HBA1 is a therapeutic target for drugs such as Voxelotor, which binds to the alpha chain to increase hemoglobin's oxygen affinity and prevent the polymerization of sickle hemoglobin. Emerging therapeutic strategies also include gene-editing technologies like CRISPR to correct genetic defects or reactivate fetal hemoglobin production to compensate for HBA1 deficiency. Additionally, the glycated form of this protein, HbA1c, serves as a vital clinical biomarker for monitoring long-term glycemic control in diabetic patients.

Other names
Alpha-globinHemoglobin alpha-1 chainHemoglobin alpha chainHBA1HBA-T3HBHMETHBAECYT7Hemopressin
02

Mechanism of action

Hemoglobin HbA positive modulator; stabilization of oxygenated hemoglobin state; inhibition of hemoglobin S polymerization

03

Biological functions

Oxygen transportNitric oxide transportBicarbonate transportNitric oxide signalingResponse to hydrogen peroxideErythrocyte developmentPeroxidase activity
04

Disease associations

Alpha-thalassemiaSickle cell diseaseAnemiaHeinz body anemiaFamilial erythrocytosis 7Hemoglobin H diseaseCerebral malaria
05

Safety considerations

Potential for tissue hypoxia due to excessive oxygen affinity stabilizationRisk of secondary polycythemiaExacerbation of hemolysis in certain hemoglobin variantsRisk of pulmonary hypertension in sickle cell patients
06

Interacting drugs

Voxelotor

4 more in the full profile.

07

Biomarkers

Hemoglobin A1c (HbA1c)Total hemoglobin levelsMean corpuscular volume (MCV)Fetal hemoglobin (HbF) levelsMean corpuscular hemoglobin (MCH)

Beyond the preview

Go deeper on Hemoglobin subunit alpha 1 (HBA1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemoglobin subunit alpha 1 (HBA1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call